chrisvoncsefalvay/vaers-outcomes huggingface dataset:
light headed/dizzy constantly; tingling in face; This is a spontaneous report from a contactable non pregnant female consumer reported for herself. A 68-year-old female patient received the first dose of bnt162b2 (BNT162B2, Solution for injection, Lot number: EL3249, Expiration date was not reported), via an unspecified route of administration, in arm right on 23Jan2021 03:15 as single dose for covid-19 immunisation. Medical history included heart burn. Patient did not have allergies to medications, food, or other products. Concomitant medications included oxybutynin, omeprazole and famotidine all are taken for an unspecified indication, start and stop date were not reported. The patient experienced lightheaded/dizzy and tingling in face on 27Jan2021. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient has not been tested for COVID-19. Patient did not receive any other vaccines within 4 weeks prior to the COVID. Patient did not receive any treatment for the adverse events. The outcome of the events was not recovered.
Symptoms included chills, headache, fatigue, lightheadedness, and soreness at the injection site. Symptoms began about 8 hours after the injection and lasted about 24 hours. Symptoms were most severe the morning after the injection (12-14 hours after the injection). Treatment included rest and hydration. Symptoms went away on their own within 36 hours.
Delayed due to due to sleep apnea; Minor sore arm; increase in energy for about 3 weeks; This spontaneous case was reported by a consumer and describes the occurrence of APNOEA (Delayed due to due to sleep apnea) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Mast cell activation syndrome (Mast cell reaction), Tachycardia (POTS) and Excessive daytime sleepiness. Concurrent medical conditions included Drug allergy (Novocain), Drug allergy (slurines), Drug allergy (singular), Drug allergy (Cromolyn sodium) and Drug allergy (Most add meds). Concomitant products included IVABRADINE HYDROCHLORIDE (CORLANOR), RIVASTIGMINE (EXELON), BUPROPION HYDROCHLORIDE (WELLBUTRIN), KETOTIFEN, CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY), FAMOTIDINE (PEPCID [FAMOTIDINE]), NALTREXONE, IMMUNOGLOBULINS NOS and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for an unknown indication.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced APNOEA (Delayed due to due to sleep apnea) (seriousness criterion medically significant), PAIN IN EXTREMITY (Minor sore arm) and ENERGY INCREASED (increase in energy for about 3 weeks). At the time of the report, APNOEA (Delayed due to due to sleep apnea), PAIN IN EXTREMITY (Minor sore arm) and ENERGY INCREASED (increase in energy for about 3 weeks) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. However, the patient's comorbidities are risk factors and confounds causality assessment. Further information has been requested.   This case was linked to MOD-2021-256730 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. However, the patient's comorbidities are risk factors and confounds causality assessment.Further information has been requested.
2 grand mal seizures the day after shot, mild (99 degree) fever the night of shot
Patient was given Zoster vaccine on two seperate occasions. 12/13/2012 at 1PM, and 06/12/2015 at 3PM. Patient displayed no physical adverse reaction to vaccine. Spoke with the patient today via telephone, and patient states at this time she feels fine, and has no symptoms. I will be contacting patient weekly for the next consecutive 4 weeks to check on her status.
Pt vaccinated on 5/5/21. On 5/6/21 he developed fatigue, body aches and chills. In the early morning of 5/8/21 (around 3am), he woke up from a sleep in his armchair and stood up, at which time he lost consciousness and passed out, hitting his head. He does not recall anything after that until he woke up in bed in the morning.
This spontaneous case was reported by a physician assistant and describes the occurrence of UNDERDOSE (lower-than-authorized dose administered) and NO ADVERSE EVENT (No adverse event) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced UNDERDOSE (lower-than-authorized dose administered) and NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (lower-than-authorized dose administered) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (lower-than-authorized dose administered). No concomitant product use was reported. HCP administered a Moderna Covid-19 vaccine 0.25 ml dose to a patient instead of a 0.5 ml for booster dose. HCP explained that the dose was pulled up from Moderna's purple top vial. No treatment information was provided.
No adverse symptoms reported; patient was administered the first dose of GARDASIL 9 in the series on an unknown date in April of 2019 when he was 58 years old; This spontaneous report was received from a pharmacist referring to a 58-year-old male patient. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications.  On an unknown day in April 2019, the patient was vaccinated with a first dose od hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (dosage schedule, route of administration, anatomical location, lot number and expiration date were not reported) for prophylaxis (product administered to patient of inappropriate age). No adverse event was reported.
2 mo imms given 11/11/10. Fever that night 102. Managed with TYLENOL. Seen in clinic 11/12/10 afebrile.
After receiving vaccine, patient experience pain and bruising at injection site almost immediately and bruise is still present 11/08/2010.
Patient was given 1st Moderna COVID19 dose instead of 1st Pfizer dose as indicated for her age (17 at time of vaccination).
Within 10 minutes of shot ears ringing very loudly and has continued for 3 weeks and counting; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on an unknown date in 2021 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included slight ear ringing but not like a train going through the patient brain like now. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On an unknown date in 2021, within 10 minutes of shot, the patient experienced ears ringing very loudly and has continued for 3 weeks and counting. Therapeutic measures were not taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event ears ringing very loudly and has continued for 3 weeks and counting was not resolved at the time of this report.   The lot number for BNT162b2 was not provided and will be requested during follow up.
Lemon size knot at site very red and hot to touch; Lemon size knot at site very red and hot to touch; Lemon size knot at site very red and hot to touch, bruiseing around edges hurts down arm; Lemon size knot at site very red and hot to touch, bruiseing around edges hurts down arm; This is spontaneous report from a contactable consumer (patient). A 44-year-old female patient (not pregnant at the time of vaccination) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 08Apr2021 at 12:00 (Lot number: Ep7533) on the left arm as single dose for COVID-19 immunization. Medical history included allergies to Msg. There were no concomitant medications that no other medications the patient received within 2 weeks of vaccination. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 18Mar2021 at 12:00 (Lot number: En6207) on the left arm as single dose for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient did not diagnose with COVID-19. Since the vaccination, the patient did not test for COVID-19. On 10Apr2021 at 10:00, patient experienced lemon size knot at site very red and hot to touch, bruising around edges hurts down arm. There was no treatment received for the adverse events. The outcome of the events was not recovered.   No follow-up attempts are needed. No further information is expected.
current outbreak that is painful lower torso; This case was reported by a physician via call center representative and described the occurrence of painful rash in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in April 2018).   In June 2018, the patient received the 2nd dose of Shingrix. On an unknown date, less than a year after receiving Shingrix, the patient experienced painful rash. On an unknown date, the outcome of the painful rash was unknown.   It was unknown if the reporter considered the painful rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient had a current outbreak and that was a painful lower torso. The physician inquired if there was any information on how to proceed with the patient. The representative had gathered all the patient information which the physician could provide.
Moderna 2/22/21, 3/25/21, 12/3/21. Positive on 6/27/22
patient received unconscious, syncope episode noted. Post vaccination stated site felt nauseous , lightheadedness and falling to floor. patient unconscious x 3. Assisted to wheelchair Ax3. At 1108am vitals monitored Pulse 59 BP 77/50 RESP 20. Fluids administered A&O x3. Verbally responsive speech clear. Injury to left eye and head noted. pain 2/10. Ice administered. 1116am Pulse 70 BP 91/67. Patient refused to go to the ER, family notified, patient is released from facility accompanied by sister.
09/11/22 presents to ED for "pelvic pain". PMHx of"mitral valve disorder, depression, neobladder, fibromyalgia, anxiety, COPD"
PATIENT EXPERIENCED EXTREME FATIGUE, TERRIBLE CRAMPING AND HEADACHE, DRY MOUTH, DEHYDRATION, AND HEART RATE WAS MEASURED TO BE 130 WHEN TAKEN TO URGENT CARE ON 11/21/15.
Patient called by 9/28/11 around 11:45A to report the PNEUMOVAX shot she got 9/27/11 has made her arm turn red, has heat, and spread from shot site - half way down to elbow I referred her to her DR. Asked her to let me know. I'm not sure what's going on here??.
This spontaneous report as received from a physician refers to a male patient of unknown age. The patient's medical history was not reported. In approximately 2013 (reported as 4 or 5 years ago), the patient was vaccinated with a dose of GARDASIL, intramuscular for prophylaxis (it was unknown if it was first or second dose in series). On an unknown date, the patient experienced facial palsy. The outcome of facial palsy was reported as recovered/resolved on an unspecified date. Causality assessment was not reported. Upon internal review, the event of facial palsy was considered to be medically significant.
Patient was found unresponsive in room and emergently transported to hospital. He required intubation and prolonged ICU stay.  He was diagnosed with meningoencephalitis.
Erythematous areas on right and left lateral thighs left area 2.5 cm in diameter, right thigh 5-6 cm diameter, tenderness, swelling, and numbness.
ADMINISTRATION ERROR: Gave High Dose Influenza vaccine to a client under 65 years of age.
This spontaneous report was received from a Certified Medical Assistant (C.MA) concerning a patient of unknown age and gender. Medical history and concurrent conditions were not reported. It was reported that on 19-OCT-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 (lot # L003188, expiration date 06-JUL-2016), (dose and route were not provided). Concomitant therapies were not provided. No adverse effects were reported. This is one of two reports from the same source (MARRS # 1512USA013609). Additional information has been requested.
Site: Pain at Injection Site-Mild, Additional Details: Patient scheduled appointment online to receive Moderna vaccine at our location. Patient received vaccine on 8/8. patient was counseled to return to pharmacy in 28 days for 2nd dose and that patient must receive moderna for 2nd dose because vaccines are not interchangeable. Patient agreed. Patient called the pharmacy 8/9 and said his daughter reminded him he had already received 1 dose of the pfizer vaccine 3-4 months prior. counseled to contact Md. Patient denies any side effects
Information has been received from a healthcare worker concerning a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant therapy were not reported. On 04-MAY-2015, the patient was vaccinated with a dose of improperly stored PROQUAD (Merck), lot # L002419, expiration date 23-JUL-2016 (dose and route not reported). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information is not expected because the physician did not wish to be contacted.
a 58 yr old female who presents with Facial Droop (since Covid shot Moderna first dose done on 4/22/21, Eyes watery, face drop mostly left side, ), Blood Pressure (would like to increase her Losartan to 2x a day), Health Maintenance (declines all HM dues for now) She reports that she had her first Moderna COVID-19 vaccine 4 days ago. The following day she developed some drooping and the left side of her face and some watery eye. By her report the symptoms are staying about the same without any improvement noted. She has not had any fever
Patient experienced fatigue along with trouble finding words when trying to speak. She reported fatigue started the day after the vaccine. It did not alarm her, but the morning (2 days after the vaccine) she had trouble conversing with another person. The words she needed to say just would not come to her. She was alarmed because this is not usually a problem for her. She felt otherwise mentally fit and is not seeking any further medical evaluation at this time.
He received his influenza vaccine by a liaison in his area. A couple of days later, he started noticing soreness in his arm and a small lesion, so he went to the Emergency Department on October 27. An ultrasound was done, which was negative. They felt that this was just a local reaction and did not rise to the level of cellulitis. He notes that it continues to be sore in the deltoid, but has also spread up into the shoulder a little bit. He has never had a significant reaction to influenza vaccine in the past.   Examination of the left deltoid reveals a small 1 millimeter erythematous open wound with no obvious signs of infection. He has mild tenderness in the deltoid. There is no palpable evidence of a deeper wound or an abscess. He has full range of motion of his shoulder
Dizziness Narrative:  employee felt light headed after vaccine, no interventions, passed quickly felt better after 20min wait time
body aches; chills; lowfever; Headache; second dose received on day 96; scheduled for their third dose; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MYALGIA (body aches), CHILLS (chills), PYREXIA (lowfever), HEADACHE (Headache) and OFF LABEL USE (second dose received on day 96) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020B21A and 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's medical history was not provided.  Concomitant products included METOPROLOL SUCCINATE (TOPROL XL), AMLODIPINE BESILATE (NORVASC), PROGESTERONE, CLONAZEPAM, FAMOTIDINE, ACETYLSALICYLIC ACID (ASPIRINE) and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Apr-2021, the patient experienced MYALGIA (body aches), CHILLS (chills), PYREXIA (lowfever), HEADACHE (Headache) and OFF LABEL USE (second dose received on day 96). 13-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (scheduled for their third dose). On 15-Apr-2021, MYALGIA (body aches), CHILLS (chills), PYREXIA (lowfever) and HEADACHE (Headache) had resolved. At the time of the report, OFF LABEL USE (second dose received on day 96) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (scheduled for their third dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Jan-2021, SARS-CoV-2 test: positive (Positive) Positive.         On 9-Jan-2021, patient went to the hospital and received an antibody infusion, BAMLAN monoclonal antibodies and came home the same day after the treatment. She was instructed to wait 90days and start the vaccination series all over again. She received her second dose on 13April 2021. The third dose is scheduled for 11-May-2021.   This case was linked to MOD-2021-083078, MOD-2021-083092 (E2B Linked Report). This case was linked to MOD-2021-083133 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-May-2021: Received TCR for. No new information provided.; Sender's Comments:  MOD-2021-083078:Husband's first dose MOD-2021-083092:Husband's second dose
Site of Moderna vaccine started slightly itching, 2/16/21.  2/17/21, after 4 mile run, same site are severe itch. Felt seizable lump. When looked, area very swollen (size of half golf ball), very red and rashy.
Vaccine was diluted incorrectly. All vaccine contents were injected to the 0.9 % sodium chloride diluent total of 2 ml. Patient was vaccinated with 0.3 ml.
lymph node swelling on both sites of his throat and below his jaw bones; severe pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (lymph node swelling on both sites of his throat and below his jaw bones) and VACCINATION SITE PAIN (severe pain at the injection site) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included FINASTERIDE and CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication.    On 18-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced VACCINATION SITE PAIN (severe pain at the injection site). On 20-Mar-2021, the patient experienced LYMPHADENOPATHY (lymph node swelling on both sites of his throat and below his jaw bones). On 22-Mar-2021, VACCINATION SITE PAIN (severe pain at the injection site) had resolved. At the time of the report, LYMPHADENOPATHY (lymph node swelling on both sites of his throat and below his jaw bones) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.
Pain began on incident date, assumed it was constipation with gas, on Tuesday 8/17/21 diagnosed with appendicitis, during laparoscopic procedure MD discovered appendix had ruptured and an open appendectomy was performed. I have an 8 inch incision from the surgeon needing to open me up and clean my abdominal cavity.
11/12, sore arm. 11/15, aching joints, tiredness & eyes hurt. No knowledge of temp. 11/16, felt better during the am, but sx's reoccurred in the evening, to a lesser degree. Aching joints, hips, wrist, knees-more at night. 11/21,felt normal
I had midline chest pain, pain that radiated down both arms to my elbows, it felt like my tongue fell asleep. I thought I had chest pains from some cheese I had eaten. My husband and I were talking, after 20 minutes I did not have any relief in my chest after taking my bra off, my neck was hurting, my tongue was feeling like it was asleep. I went to the emergency room my blood pressure was 134/85 which is high for me, the put leads on me for an EKG, it showed that I was having a STEMI. She instructed me to change my clothes so that they could get me upstairs to get me taken care of, they could not fit the stent in. I stayed in ICU for three days.
Report tingling of spine, itchy palms and eyes tightness of chest, diarrhea 4 days after vaccination .  Report the same symptoms as other medication she is allergic  to. Treatment: Antihistamine  Outcome: symptoms has resolved. Instructed by PCP not to get the second vaccine.
Patient comes back in January 2012 complaining of blisters on his leg he believes were shingles blisters from ZOSTAVAX vaccine. Patient comes back today (3/13/12) complaining ZOSTAVAX shot exacerbated his fibromyalgia. No treatment.
"we both don't feel well"; This spontaneous case was reported by a  Female  age 67-year-old Patient who received the moderna vaccine in the Left arm on 18Jan2021.and  Patient  reported her spouse,71-year-old male patient, also received the moderna  vaccine in his Left arm on 18Jan2021.and describes the occurrence of Felling abnormal ("we both don't feel well") Caller wants to know if they can take aspirin. Caller also would like to know if she can take her antihistamines which she takes for allergies.No Medical History information was reported. Outcome of the event is unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-009911 (Patient Link).